Tag Archives | INEOS

ineos.jpg

INEOS’ covenant waiver request causes concern

INEOS is the world’s 3rd largest chemicals company. Its €7.29bn debt burden ($9.2bn) means that it is also Europe’s largest issuer of high yield debt. This is an unfortunate combination, given today’s chemical markets. Last month, INEOS was forced to ask its lenders for a waiver on its debt covenants. It offered to pay a […]

Continue Reading

LyondellBasell debt downgraded, INEOS seeks waivers

Current market conditions are causing problems for everyone in the chemical industry. But as the blog has long feared, they are particularly testing those companies with higher debt levels. On Friday, Moody’s announced a downgrading of the Corporate Family Rating of Lyondell Basell Industries to B3 to B1, and said the outlook “remains negative”. Yesterday, […]

Continue Reading
ineos.jpg

Ineos to sell some US assets?

The UK’s Sunday Telegraph newspaper reports that ‘Ineos, the chemicals group which is one of Britain’s biggest private companies, is considering selling assets in an effort to reduce its debt burden’. It adds that ‘the company, which has expanded rapidly through debt-fuelled acquisitions, is understood to be looking at disposing of a number of businesses […]

Continue Reading

INEOS’ Grangemouth plants on strike

Ineos’ 200,000bpd Grangemouth refinery in Scotland is on strike today and tomorrow, over a pension dispute. This will presumably cost the workers 2 days pay. The costs for INEOS and the UK are enormous in comparison. BP, for example, has had to shut down a pipeline that carries 40% of the UK’s oil production, because […]

Continue Reading

BP and Reliance

BP and Reliance Industries are both powerhouses in their own fields. BP’s new CEO, Tony Hayward, has just given his first interview in the new job. Comparing, and contrasting, his comments with last week’s AGM statement by Reliance’s Chairman, Mukesh Ambani, is very revealing in terms of content as well as tone. Hayward’s interview in […]

Continue Reading

Chemical company valuations

The prices paid for Petkim and for Lustran reflect two very different perspectives on the current market:

Continue Reading